Sandra Kuntz

Vandoeuvre-les-nancy, 54506, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy.

CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy.

Journal: Cancers
Published: September 16, 2022

AB186 Inhibits Migration of Triple-Negative Breast Cancer Cells and Interacts with α-Tubulin.

AB186 Inhibits Migration of Triple-Negative Breast Cancer Cells and Interacts with α-Tubulin.

Journal: International journal of molecular sciences
Published: May 25, 2022

Claudin 1 inhibits cell migration and increases intercellular adhesion in triple-negative breast cancer cell line.

Claudin 1 inhibits cell migration and increases intercellular adhesion in triple-negative breast cancer cell line.

Journal: Molecular biology reports
Published: May 18, 2020

Biotinylation enhances the anticancer effects of 15d‑PGJ2 against breast cancer cells.

Biotinylation enhances the anticancer effects of 15d‑PGJ2 against breast cancer cells.

Journal: International journal of oncology
Published: October 27, 2017

Erratum to: Pro-apoptotic effect of Δ2-TGZ in "claudin-1-low" triple-negative breast cancer cells: involvement of claudin-1.

Erratum to: Pro-apoptotic effect of Δ2-TGZ in "claudin-1-low" triple-negative breast cancer cells: involvement of claudin-1.

Journal: Breast cancer research and treatment
Published: August 02, 2017

Pro-apoptotic effect of Δ2-TGZ in "claudin-1-low" triple-negative breast cancer cells: involvement of claudin-1.

Pro-apoptotic effect of Δ2-TGZ in "claudin-1-low" triple-negative breast cancer cells: involvement of claudin-1.

Journal: Breast cancer research and treatment
Published: May 11, 2017

Reprofiling of Troglitazone Towards More Active and Less Toxic Derivatives: A New Hope for Cancer Treatment?

Reprofiling of Troglitazone Towards More Active and Less Toxic Derivatives: A New Hope for Cancer Treatment?

Journal: Current topics in medicinal chemistry
Published: July 24, 2015

Energy restriction mimetic agents to target cancer cells: comparison between 2-deoxyglucose and thiazolidinediones.

Energy restriction mimetic agents to target cancer cells: comparison between 2-deoxyglucose and thiazolidinediones.

Journal: Biochemical pharmacology
Published: June 20, 2014

Optimization of troglitazone derivatives as potent anti-proliferative agents: towards more active and less toxic compounds.

Optimization of troglitazone derivatives as potent anti-proliferative agents: towards more active and less toxic compounds.

Journal: European journal of medicinal chemistry
Published: January 31, 2014

PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells.

PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells.

Journal: Molecular carcinogenesis
Published: May 23, 2013

Tex 19 paralogs exhibit a gonad and placenta-specific expression in the mouse.

Tex 19 paralogs exhibit a gonad and placenta-specific expression in the mouse.

Journal: The Journal of reproduction and development
Published: March 27, 2012

Synthesis of new troglitazone derivatives: anti-proliferative activity in breast cancer cell lines and preliminary toxicological study.

Synthesis of new troglitazone derivatives: anti-proliferative activity in breast cancer cell lines and preliminary toxicological study.

Journal: European journal of medicinal chemistry
Published: November 09, 2011
Showing 1-12 of 12

Last Updated: 09/26/2026